Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
VSTM
VERASTEM, INC.
NASDAQ
$7.51
▲ UP 2.60% (0.19)

KEY STATISTICS

Market Cap$643.23 M
52w High$10.82
52w Low$3.43
Dividend Yield—
Frequency—
P/E-3.00
Volume1.51M
Shares Out.87.87M

COMPANY

LEADERSHIP

Daniel W. Paterson
CHIEF EXECUTIVE
Daniel W. Paterson

COMPENSATION 2026

Salary$674,000
Stock Awards$1,161,661
Incentive Plan Pay$489,324
All Other Comp.$24,990
Total$2,349,975

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 27, 2012
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
102

PRICE TARGET

Target High$18.00
Target Low$8.00
Target Median$13.50
Target Consensus$13.83

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$29.13M
NOV
3
TUE

SPLIT RECORD

DATETYPERATIO
2023-06-01Reverse1:12

PRICE

$7.51 ▲ UP 2.60% (+$0.19)
OVERLAYS
$7.30$7.40$7.50$7.609:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM7.51

About Verastem, Inc.

https://www.verastem.com ↗

Verastem, Inc. is a biopharmaceutical company developing cancer treatments like VS-6766, a RAF/MEK inhibitor, through clinical trials and collaborations with Pfizer, Chugai, and Amgen.

INDUSTRY

Biotechnology

A PRODUCT VERASTEM, INC. IS KNOWN FOR

AVMAPKI™ FAKZYNJA™ CO-PACK
AVMAPKI™ FAKZYNJA™ CO-PACK

Verastem Oncology's first FDA-approved targeted combination therapy of avutometinib and defactinib treats adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer.

COMPETITORS

COMPETITOR
AMGN COMPARE
BMY COMPARE
NVS COMPARE
PFE COMPARE
RVMD COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
70
LISTED HERE
13
RANKED BY POSITION SIZE
XBI
0.24% · 3.6M
VTS.AX
0.00% · 2.8M
IWM
0.02% · 2.1M
FESM
0.09% · 800.8K
BBP
2.30% · 389.7K
LABU
0.18% · 129.6K
PRFZ
0.02% · 81.7K
XRSU.L
0.02% · 68.4K
RSSL
0.02% · 38.3K
URTY
0.01% · 3.1K
VETS
0.03% · 1.7K
RESM
0.02% · 156
AVTM
0.00% · 107

INSTITUTIONAL OWNERSHIP

SHARES OWNED
69.93%
HOLDERS
248
TOP 12 OF 248 · RANKED BY POSITION SIZE
Blackrock, Inc.
9.2M sh · $35.12M
Armistice Capital, LLC
7.0M sh · $26.83M
Rtw Investments, LP
6.6M sh · $25.35M
Deep Track Capital, LP
5.7M sh · $21.93M
State Street Corp
5.1M sh · $19.61M
Vanguard Group Inc
4.2M sh · $32.06M
Balyasny Asset Management L.P.
4.1M sh · $36.62M
Logos Global Management LP
4.0M sh · $35.76M
Rosalind Advisors, Inc.
4.0M sh · $15.23M
Polar Capital Holdings Plc
3.9M sh · $30.3M
Point72 Asset Management, L.P.
3.9M sh · $34.25M
Nantahala Capital Management, LLC
3.6M sh · $19M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Paterson Dan
Sale · 1.3K shares
2026-08-03
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Paterson Dan
Sale · 20.9K shares
2026-06-22
★
OFFICER: CHIEF FINANCIAL OFFICER
Calkins Daniel
Sale · 4.0K shares
2026-06-22
★
OFFICER: CHIEF FINANCIAL OFFICER
Calkins Daniel
Sale · 57 shares
2026-06-22

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
OUTPERFORM 2
6 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY BTIG BUY Mizuho OUTPERFORM Guggenheim BUY RBC Capital OUTPERFORM Jefferies BUY

SECTORS PEERS

PEERPRICE
ABSI$8.14COMPARE
CRVS$13.17COMPARE
MLTX$12.72COMPARE
OLMA$10.15COMPARE
FDMT$14.10COMPARE
PRTA$8.92COMPARE
RGNX$8.63COMPARE
GOSS$10.76COMPARE